This document provides learning outcomes for training stop smoking practitioners. It begins with an introduction explaining the purpose and importance of evidence-based behaviour change techniques in behavioural support.
The document is then divided into two main sections - knowledge and practice. The knowledge section lists learning outcomes related to understanding smoking patterns, health effects, challenges of quitting, and treatments. The practice section outlines competencies for assessing clients, planning support, delivering support techniques to enhance motivation, manage cravings, and use medications effectively.
Sixteen behaviour change techniques are indicated that have the strongest evidence for effectiveness. The goal is to train practitioners to competently deliver an evidence-based intervention that significantly increases a client's chances of successfully quitting smoking
This poster was presented at the 45th Union World Conference on Lung Health in 2014. It outlines the interim findings of a study that tests behaviour change interventions aimed at lung health patients in Nepal
Presentation describing the DMA INSIGHT programme and its use in collaboration with St Andrews Hospital Charity to develop person centred integrated care pathways - presented at International Forensic Conference - UCLAN
Competence-Based Training for a National Stop-Smoking Service: An English Cas...Global Bridges
Presentation by Andy McEwen, Ph.D., National Centre for Smoking Cessation and Training, UK, at the 15th World Conference on Tobacco OR Health in Singapore.
This poster was presented at the 45th Union World Conference on Lung Health in 2014. It outlines the interim findings of a study that tests behaviour change interventions aimed at lung health patients in Nepal
Presentation describing the DMA INSIGHT programme and its use in collaboration with St Andrews Hospital Charity to develop person centred integrated care pathways - presented at International Forensic Conference - UCLAN
Competence-Based Training for a National Stop-Smoking Service: An English Cas...Global Bridges
Presentation by Andy McEwen, Ph.D., National Centre for Smoking Cessation and Training, UK, at the 15th World Conference on Tobacco OR Health in Singapore.
Breakout 2.2 Commissioning Quality Care: Tools to support the commissioning p...NHS Improvement
Breakout 2.2 Commissioning Quality Care: Tools to support the commissioning process - Stephen Callaghan:
Principal Consultant, EQE Health.
Associate Consultant, Hope Street Centre.
Visiting Lecturer, University of Chester.
ANP, A&E University Hospitals Aintree
Part of a set of presentations from NHS Improvement event: Better value, better outcomes held on Thursday 21 February 2013,
Guoman Tower Hotel, London
How to deliver quality and value in chronic care:sharing the learning from the respiratory programme
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
Mind the gap: ways to enhance therapy provision in stroke rehabilitation
This document, being launched at the UK Stroke Forum this week, explores some of the different models adopted by therapy services to deliver more rehabilitation and provides further detail about 45 minutes, process and outcomes.
(Published November 2011)
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Naz Usmani
A very brief presentation about the clinical process improvements including practices, standards of care , guideline and pathway . I have reflected upon the basic differences between them . Hope it is useful
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
CBRT - "A Case for NHS Adoption." 05.04.13Alison Bourne
33 slides POWERPOINT : “CBRT A Case for NHS Adoption - Providing patients with structured relaxation support sessions. CBRT provides the NHS with a Value for Money, practical and unique system for physical
health, mental health and wellbeing.
• CBRT provides a ‘safe care’ and ‘right care’ solution to the ever growing requirement for
increased capacity within integrated care for patients with anxiety, mild to medium
depression and long term conditions. This need was highlighted in the report, “How Mental
Illness Loses Out in the NHS”, produced by a distinguished team of economists,
psychologists, doctors and NHS managers convened by Professor Lord Layard of the LSE
Centre for Economic Performance.
• CBRT can contribute to productive patient care and strengthen staff and patient
communication skills; CBRT is empowering.
• CBRT is a high quality, yet low cost product.
• A relaxation technique and therapeutic intervention - CBRT is a safe product. It is a potential CE Class 1 Medical Device and is made of printed matter.
• CBRT is a motivational, inclusive, non-pharmaceutical, non-invasive, non-denominational
and non-tactile intervention, for all ages and abilities.
Prescribing, administration and supply of medicines by allied health professi...MS Trust
This presentation by Helen Marriott, AHP Medicines Project Lead, looks at prescribing and medicines supply mechanisms and the AHP Medicines Project.
It was presented at the MS Trust Annual Conference in November 2014.
Breakout 2.2 Commissioning Quality Care: Tools to support the commissioning p...NHS Improvement
Breakout 2.2 Commissioning Quality Care: Tools to support the commissioning process - Stephen Callaghan:
Principal Consultant, EQE Health.
Associate Consultant, Hope Street Centre.
Visiting Lecturer, University of Chester.
ANP, A&E University Hospitals Aintree
Part of a set of presentations from NHS Improvement event: Better value, better outcomes held on Thursday 21 February 2013,
Guoman Tower Hotel, London
How to deliver quality and value in chronic care:sharing the learning from the respiratory programme
The best of clinical pathway redesign - practical examples of delivering bene...NHS Improvement
The examples here showcase just some of the innovations that have enabled thousands of patients to enjoy better health and well-being thanks to practicalservice improvements implemented on various clinical pathways
Mind the gap: ways to enhance therapy provision in stroke rehabilitation
This document, being launched at the UK Stroke Forum this week, explores some of the different models adopted by therapy services to deliver more rehabilitation and provides further detail about 45 minutes, process and outcomes.
(Published November 2011)
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Naz Usmani
A very brief presentation about the clinical process improvements including practices, standards of care , guideline and pathway . I have reflected upon the basic differences between them . Hope it is useful
A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment
Led by the AHSN Network
Day One, Pop-up University 8, 11.00
CBRT - "A Case for NHS Adoption." 05.04.13Alison Bourne
33 slides POWERPOINT : “CBRT A Case for NHS Adoption - Providing patients with structured relaxation support sessions. CBRT provides the NHS with a Value for Money, practical and unique system for physical
health, mental health and wellbeing.
• CBRT provides a ‘safe care’ and ‘right care’ solution to the ever growing requirement for
increased capacity within integrated care for patients with anxiety, mild to medium
depression and long term conditions. This need was highlighted in the report, “How Mental
Illness Loses Out in the NHS”, produced by a distinguished team of economists,
psychologists, doctors and NHS managers convened by Professor Lord Layard of the LSE
Centre for Economic Performance.
• CBRT can contribute to productive patient care and strengthen staff and patient
communication skills; CBRT is empowering.
• CBRT is a high quality, yet low cost product.
• A relaxation technique and therapeutic intervention - CBRT is a safe product. It is a potential CE Class 1 Medical Device and is made of printed matter.
• CBRT is a motivational, inclusive, non-pharmaceutical, non-invasive, non-denominational
and non-tactile intervention, for all ages and abilities.
Prescribing, administration and supply of medicines by allied health professi...MS Trust
This presentation by Helen Marriott, AHP Medicines Project Lead, looks at prescribing and medicines supply mechanisms and the AHP Medicines Project.
It was presented at the MS Trust Annual Conference in November 2014.
NHS Improving Quality undertook a scoping exercise of rehabilitation services, which included:
Identification of the different practice models illustrated through case studies looking at integrated models of adult rehabilitation service provision
A high level baseline mapping exercise of the current availability of adult rehabilitation services across England.
NHS Improving Quality also assisted in capturing the views from key stakeholders by supporting and facilitating a series of stakeholder engagement events hosted by NHS England.These events aimed to develop and agree principles and expectations to underpin high quality rehabilitation services.
Canadian Psychological Association For Cameron NormanCameron Norman
Presentation at the CPA convention on the work done by the CAN-ADAPTT project. Norman, C.D. & Selby, P. (2010, June). CAN-ADAPTT: Developing a Canadian Smoking Cessation Guideline. Presentation at the annual meeting of the Canadian Psychological Association, Winnipeg, MB, June 3, 2010.
This presentation will address efforts by the ATTC Network to decrease the gap between research and practice and to influence understanding of factors that enhance uptake of innovations. This presentation outlines how pairing research with innovative dissemination techniques can enhance the use of EBPs related to MAT. The presentation will provide an overview of the Buprenorphine Suite, a training product designed by the ATTC Network to provide the SUD treatment field with the tools to access and adopt NIDA treatment protocols. Additionally this presentation will identify research undertaken by the Network which identifies barriers to providing MAT to minority populations.
BPS DCP SIGOPAC Good Practice Guidance in Demonstrating Quality and Outcomes ...Alex King
This report outlines a rigorous, multidimensional framework for evaluating quality and outcomes in psycho-oncology services, which can be flexibly adapted to local needs and priorities.
It aims to challenge psycho-oncology services to develop and standardise procedures that address the clinical and operational aspects of quality, while maintaining a firm focus on the experiential.
The proposed framework focuses on six key domains of service quality:
- Is this service safe?
- Is this service equitable, while also focused on those most in need?
- Is this service timely and responsive?
- Is this service respectful, collaborative and patient-centred?
- Is this service offering effective interventions?
- Is this service contributing to efficient multidisciplinary care?
To address these domains, psycho-oncology services need to draw on multiple, convergent sources of data, including key performance indicators, activity levels, patient self-report measures, feedback from professional colleagues, etc.
2006 a space oddity – the great pluto debate science _ the guardianGeorgi Daskalov
Long known as the ninth planet, Pluto was downgraded in 2006, sparking a scientific spat that raises basic questions about how we understand the universe
Getting cytisine licensed for use world-wide: a call to actionGeorgi Daskalov
Most tobacco users live in low and middle income countries where stop smoking medicines are unavailable or unaffordable. There is an urgent need for action by key stakeholders to get cytisine licensed worldwide so that its life-saving potential can be realised.
Evaluation of the efficacy and safety of tribulus terrestris in male sexual d...Georgi Daskalov
Evaluation of the efficacy and safety of tribulus terrestris in male sexual dysfunction – a prospective, randomized, double blinded, placebo controlled clinical trial 2015 poster
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
3. 3NCSCT Training Standard
Contents
1. Purpose of this document 4
2. Introduction 5
3. Knowledge 8
3.1 Smoking in the population 8
3.2 Smoking and health 8
3.3 Why stopping smoking can be difficult 9
3.4 Smoking cessation treatments 9
3.5 The wider context 9
4. Practice 10
4.1 Assessment 10
4.2 Planning behavioural support 10
4.3 Delivery of behavioural support 11
4.4 Group interventions 14
5. References 15
4. 4 NCSCT Training Standard
1. Purpose of this document
■ This document lists the learning outcomes of training courses for stop smoking practitioners
founded upon evidence-based behaviour change techniques and approved by a panel of
key stakeholders and experts convened by the National Centre for Smoking Cessation
and Training (NCSCT).
■ This second edition of the NCSCT Training Standard has been edited to refine the
language used and to improve the document’s usability. It also indicates which learning
outcomes relate to individual behaviour change techniques for which we have most
evidence of effectiveness.
■ This second edition also gives some detail on how the behaviour change techniques
were identified and how we established evidence of their effectiveness.
■ The NCSCT Training Standard is intended to meet the needs of individuals and organisations
that commission or deliver stop smoking services.
■ The NCSCT Training Standard does not cover learning outcomes for training to deliver
brief advice for smokers aimed at motivating them to make a quit attempt. These learning
outcomes and an online module on delivering very brief advice on smoking can be found
on our website: www.ncsct.co.uk.
■ This document also does not cover learning outcomes for additional smoking cessation
training applicable to special groups such as pregnant smokers and those with mental
health problems. However, all of the learning outcomes in this training standard are
converted from behaviour change techniques that can be adapted for use with all smokers,
including pregnant smokers and those with mental health problems. Two online specialty
training modules addressing the needs of these smokers form part of the NCSCT Training
and Assessment Programme; that is available on our website: www.ncsct.co.uk.
■ This document only covers learning outcomes and does not address the broader issue
of necessary qualification and experience of trainers
■ The NCSCT Trainers Course will soon be available on the NCSCT website and will provide
training and assessment in delivering training on the core behaviour change techniques
for smoking cessation
5. 5NCSCT Training Standard
2. Introduction
The English Stop Smoking Services consist of a national network of funded clinical services
to help smokers to stop. They provide a combination of behavioural support and medication.
Research shows that they have the potential to increase smokers’ chances of stopping by
300% (West et al, 2000; Ferguson et al, 2005; Lancaster & Stead, 2005; Stead & Lancaster,
2005; West, 2010).
To work effectively, the English Stop Smoking Services should be configured with:
1. a full-time equivalent service manager with up-to-date knowledge and experience
of providing specialist behavioural support for smoking cessation
2. a core group of Stop Smoking Practitioners1 trained to an appropriate standard and
working from evidence-based treatment manuals
and they should offer:
3. both group-based and individual face-to-face behavioural support; telephone-based
support may also be offered in addition
4. all medications approved by the National Institute for Health and Clinical Evidence
(NICE) as first-line treatment
and they should:
5. collect data on 4-week quit rates in accordance with the Russell Standard (clinical), being
careful only to count smokers who have actually set a quit date with a Stop Smoking
Practitioner and been offered multi-session behavioural support. Successes are those who
report not having smoked at all for the previous two weeks with at least 85% of these
claimed quits being confirmed by an expired air-carbon monoxide concentration of less
than 10ppm.
1. Stop Smoking Practitioners are health professionals who are selected, trained and employed to deliver behavioural support
to help smokers to stop. Their role, or a major part of it, is to provide cessation support to smokers.
6. 6 NCSCT Training Standard
All smokers in the country deserve high quality evidence-based behavioural support. For this
to be achieved, Stop Smoking Practitioners need to be trained to a minimum standard and
be able to demonstrate competence to fulfill their role.
Therefore training courses should cover relevant topics, as indicated by a set of learning outcomes.
This document lists a set of learning outcomes that have been agreed as essential for individual
and group face-to-face smoking cessation interventions. In some cases, they are based on the
need for Stop Smoking Practitioners to be able to accurately answer queries from clients on
matters relating to smoking and smoking cessation. In other cases they are required for safe
professional practice and in some cases they are based on a systematic analysis of behaviour
change techniques that have a reasonable evidence base to support their use.
It is expected that to achieve these learning outcomes would require a minimum of 30 hours
of study.
This current document supersedes the first edition of the NCSCT Training Standard which
in turn superseded the Standard for Training in Smoking Cessation Treatments in England
(Health Development Agency, 2003) and reflects the clinical, policy and research developments
that have taken place since the original document was published. This NCSCT Training Standard
– Learning Outcomes for Training Stop Smoking Practitioners document was originally
commissioned by the Department of Health as part of the National Centre for Smoking
Cessation and Training (NCSCT) work programme.
The content of this training standard was informed by the practical experience of Stop Smoking
Practitioners currently working for and running Stop Smoking Services, reviews of research
evidence and existing training programmes, and through consultation with an expert panel
comprised of clinicians, service managers, commissioners, academics and policy advisers.
7. 7NCSCT Training Standard
The importance of evidence-based behaviour change techniques
■ Knowledge itself is not enough to engender behaviour change, either in smokers or
health professionals
■ The NCSCT recognised that it needed to train practitioner in the competences
(knowledge and skills) that would make a significant difference (add value) to the
quit attempt that practitioners were assisting with
■ Although we knew that behavioural support roughly doubled smokers chances of success
(similar to the effect of medications), we did not know what the ‘active ingredients’ were.
This was our first task.
■ The first thing we did was to develop a reliable taxonomy of behaviour change techniques
used in behavioural support for smoking cessation. This provided a starting point for
investigating the association between intervention content and outcome and formed the
basis for determining competences required to undertake the role of stop smoking specialist:
Michie S, Hyder N, Walia A, West R (2011) Development of a taxonomy of behaviour
change techniques used in individual behavioural support for smoking cessation. Addictive
Behaviors, 36 (4), 315–319, doi: 10.1016/j.addbeh.2010.11.016
■ We then established that it is possible to identify competences recommended for behavioural
support for smoking cessation and subsets of these supported by different types of evidence.
This approach was used to form the basis for the development of the NCSCT Training and
Assessment programme for stop smoking specialists: Michie S, Churchill S, West R (2011)
Identifying evidence-based competences required to deliver behavioural support for smoking
cessation. Annals of Behavioral Medicine, 41(1), 59–70, doi: 10.1007/s12160-010-9235-z
■ Based on treatment protocols and international guidelines, plus evidence from randomised
controlled trials and expert clinical opinion, there are 16 individual behaviour change
techniques for which we have good grounds to believe that they are the most effective.
The learning outcomes relating to these 16 behaviour change techniques are indicated
in this document by a orange diamond [ ◆ ]
■ More on the evidence underpinning the NCSCT activities and on research outputs can
be found here: www.ncsct.co.uk/pub_research.php
8. 8 NCSCT Training Standard
3. Knowledge
Learning resources and training course content should result in Stop Smoking
Practitioners being able to do the following:
3.1 Smoking in the population
■ describe prevalence and patterns of smoking and smoking cessation as functions of
demographic characteristics such as gender, age, ethnicity and socio-economic status
■ describe prevalence and patterns of smoking and smoking cessation in special groups,
such as pregnant smokers and those with mental health problems
■ describe changes in smoking and smoking cessation patterns over time and across
different demographic groups
3.2 Smoking and Health
■ list the major life-threatening and non life-threatening diseases to which smoking contributes
■ describe the health benefits of cessation
■ quantify the increased risk of premature death from smoking and the benefits of
cessation at different ages
■ describe the harmful effects of smoking during pregnancy and breast feeding
■ give an accurate and balanced indication of any potential beneficial effects of smoking
■ describe the harmful effects of secondhand smoke
■ describe any effects of stopping smoking on dosages of drugs used to treat conditions
such as psychotic disorders
9. 9NCSCT Training Standard
3.3 Why stopping smoking can be difficult
■ accurately describe the process of stopping smoking in a way that reflects that attempts
to stop can be arrived at suddenly or gradually, the importance of avoiding ‘lapses’, the
factors that promote and deter quit attempts and factors that protect against and
promote relapse
■ explain what is meant by tobacco addiction and nicotine dependence and how these develop
■ list known nicotine withdrawal symptoms and their natural time course
■ describe the common reasons smokers give for why they smoke and how far these
reflect the true effects of smoking
■ describe environmental, socio-demographic and psychological factors associated
with cigarette addiction
3.4 Smoking cessation treatments
◆ describe the principles, and long-term and short-term effectiveness, of behavioural
support (individual and group-based)
■ identify potential difficulties associated with providing group-based support, such as
patient recruitment and organisational logistic demands, and how these can be addressed
◆ describe the full range of evidence-based medications available to aid smoking cessation,
including their efficacy; correct use; contra-indications and cautions, drug interactions,
side-effects; and relevant clinical guidelines
■ explain why complementary therapies and unproven commercial treatment programmes
for smoking cessation should not be made available
◆ show understanding of the principles and methodology of measurement of biomarkers
of smoking, such as carbon monoxide (CO) and cotinine
3.5 The wider context
■ show awareness of the contribution of smoking cessation to public health and to
reducing health inequalities
■ demonstrate understanding of the role of smoking cessation plays in wider tobacco
control strategies
■ describe the cost effectiveness of smoking cessation interventions compared with other
life-saving clinical interventions
10. 10 NCSCT Training Standard
4. Practice
Learning resources and training course content should result in Stop Smoking
Practitioners being able to do the following:
4.1 Assessment
◆ assess a client’s current commitment, readiness and ability to quit throughout the
quitting process
■ assess a client’s past smoking behaviour, including past history of quit attempts
◆ assess a client’s current self-reported and CO-validated smoking behaviour and deal
appropriately with any discrepancies that may arise between these
■ assess a client’s level of available social support, including assessment of the client’s
contacts who smoke
■ assess a client’s degree of nicotine dependence using validated tools such as the
Fagerström test for Nicotine Dependence (FTND), the Heaviness of Smoking Index (HSI)
or the Urges to Smoke scale
■ assess a client’s nicotine withdrawal symptoms
■ pragmatically assess a client’s psychological state (e.g. depressed mood) insofar as it
is relevant to the quit attempt
4.2 Planning behavioural support
◆ assist the client to set a quit date
■ use relevant information from a client to tailor behavioural support
■ show an appreciation of client choice, and emphasise a client’s choice and preferences
within the bounds of evidence-based practice
11. 11NCSCT Training Standard
4.3 Delivery of behavioural support
Directly addressing motivation in relation to smoking and smoking cessation
■ provide the client with accurate information on the consequences of smoking and
smoking cessation in a way that maximises motivation to quit or stay quit
◆ describe to the client the principles and effectiveness of typical behavioural support
and pharmacological therapies that can support a quit attempt
◆ apply appropriate behavioural support strategies to enhance a client’s motivation
and self-efficacy
■ maximise the client’s commitment by asking them to affirm a strong commitment
to start, continue, or restart the quit attempt
■ assist the client in identifying their reasons for wanting to stop smoking and address
concerns that they may have about the possible negative aspects of stopping
◆ emphasise to the client the importance of, and secure commitment to, the ‘not a puff’
rule once the quit date has been reached
◆ deal appropriately with ‘lapses’ to minimise the likelihood that they will lead to full ‘relapse’
■ provide feedback on a client’s performance and progress towards becoming a permanent
non-smoker, including praise contingent on successfully remaining abstinent
■ help to strengthen the client’s ‘ex-smoker’ identity (e.g. encouraging the smoker to
regard smoking as no longer part of his or her life)
12. 12 NCSCT Training Standard
Supporting the client to exercise self-control
■ accurately describe to the client what they may experience in terms of nicotine withdrawal
symptoms and suggest evidence-based approaches to alleviate these
◆ discuss barriers, triggers, and relapse predictors and assist the client in developing appropriate
strategies to cope with them
■ assist the client in setting achievable goals (e.g. one day at a time) that support the aim
of remaining abstinent, and prompt frequent review of progress towards the goal of
being permanently smoke-free
◆ use expired air CO measurement as a motivational tool to assess the extent of a client’s
smoke exposure prior to quitting and to confirm successful abstinence
◆ advise on the restructuring of the client’s social life, including specific advice on avoiding
exposure to social cues for smoking
■ discuss potential ways of changing the client’s daily routines and physical environment
in order to minimise exposure to smoking cues (e.g. removing ashtrays)
■ suggest ways of minimising stress and other psychological demands so as to conserve
mental resources
■ for concerned clients, outline weight and alcohol/caffeine consumption control methods
Promoting effective medication use and other supporting activities
◆ describe to clients the full range of pharmacological therapies available and how they
work; and assist clients in choosing which pharmacological therapy is best suited to
their needs, giving practical information and/or demonstrations on their use and monitoring
the continued suitability of the chosen product
◆ assess the client’s experience of any stop smoking medications that they are using,
including enquiries into their usage, side effects and experienced benefits
◆ advise clients appropriately on adjusting medication usage in the light of their experiences
■ enact the necessary local procedures to ensure the client receives their medication easily
◆ facilitate and advise on the client’s use of social support from friends, relatives, colleagues,
or ‘buddies’
■ provide options for obtaining additional and later support (including telephone and
online support) where these are available
13. 13NCSCT Training Standard
General communication
◆ build rapport with clients
■ communicate in an empathic and non-judgmental manner, using reflective listening
and providing reassurance throughout
■ elicit the client’s views and questions on smoking, smoking cessation, and any aspect
of behavioural support, answering questions in a clear and accurate manner
◆ describe to the client the expectations regarding the treatment programme, including
its typical length and content, plus what it requires of the client
◆ explain the reasons for measuring CO both prior to and after the quit date
■ distinguish between appropriate and inappropriate written materials, and should they
be required, offer/direct the client to appropriate materials in ways that promote their
effective use
■ provide clients with summaries of the information they have received and prompt
confirmation from the clients regarding any decisions or commitments they have made
Professional practice
■ keep accurate records for personal use of the numbers of clients seen, and Russell
Standard (clinical) success rates
■ accurately record information necessary for local and national monitoring
■ regularly reflect on own practice and assess possible areas for improvement
■ undertake the duties of a Stop Smoking Practitioner in a way that meets the appropriate
ethical standards
■ obtain and accurately interpret important new information that relates to their clinical practice
14. 14 NCSCT Training Standard
4.4 Group-based behavioural support
In addition to the learning outcomes already listed for individual support, learning
resources and training course content should result in Stop Smoking Practitioners
being able to do the following:2
Planning behavioural support in (closed) group contexts
■ assess a client’s suitability for group support
■ plan, organise, establish and run a stop smoking group
■ manage problems of comorbidity (psychological and physical) within the group appropriately
Maximising motivation to quit within the (closed) group context
■ stimulate and facilitate supportive group discussions
■ apply techniques, such as group tasks or placing of chairs, to reinforce group interaction
and enhance mutual group support and/or bonding
■ encourage clients to make public promises/contracts with other group members
■ foster a sense of responsibility to the group
■ encourage group members to compare their CO readings
■ facilitate communication of group member identities
(e.g. using name badges, encouraging client’s to talk about themselves)
■ report on missing members appropriately so as to maintain group motivation
Supporting activities in the (closed) group context
■ facilitate choice of medications in a group context
■ encourage sharing of experiences of medication use
Communication in the (closed) group context
■ describe the content of group support sessions and ways in which group processes can
sustain or enhance motivation to stop smoking, and to help create accurate positive
treatment expectations
2. These learning outcomes are in addition to those required for individual behavioural support
15. 15NCSCT Training Standard
5. References
Ferguson, J., Bauld, L., Chesterman, J., & Judge, K. (2005). The English smoking treatment
services: one-year outcomes. Addiction, 100 Suppl 2: 59–69.
Health Development Agency (2003) Standard for training in smoking cessation treatments.
Health Development Agency, London.
Lancaster, T., & Stead, L. F. (2005) Individual behavioural counselling for smoking cessation.
Cochrane Database Syst Rev (2), CD001292.
Stead, L. F., & Lancaster, T. (2005) Group behaviour therapy programmes for smoking cessation.
Cochrane Database Syst Rev (2), CD001007.
West, R., McNeill, A. & Raw, M. (2000) Smoking cessation guidelines for health professionals:
an update. Thorax; 55(2): 987–99.
West, R (2010) Summary of findings from the Smoking Toolkit Study. www.smokinginengland.info